Concord Biotech Ltd. - Research Center
543960 CONCORDBIO Group (B) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sales | 853.17 | 712.93 | 616.40 | 512.33 | 436.01 |
| Operating profit | 343.29 | 273.28 | 327.11 | 204.07 | 180.48 |
| Interest | 4.51 | 5.48 | 0.52 | 0.70 | 0.69 |
| Gross profit | 374.09 | 291.21 | 340.69 | 234.74 | 197.23 |
| EPS (Rs) | 22.76 | 18.78 | 24.74 | 17.77 | 12.45 |
Annual
results in details
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Other income | 35.31 | 23.42 | 14.10 | 31.37 | 17.44 |
| Stock adjustment | -15.63 | -23.98 | -39.05 | -4.85 | -1.16 |
| Raw material | 167.07 | 157.26 | 131.17 | 124.01 | 100.68 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 110.28 | 95.69 | 69.47 | 62.24 | 51.82 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 248.16 | 210.69 | 127.70 | 126.86 | 104.18 |
| Provisions made | - | - | - | - | - |
| Depreciation | 54.03 | 50.05 | 27.52 | 21.25 | 19.31 |
| Taxation | 81.93 | 62.59 | 77.83 | 44.53 | 59.53 |
| Net profit / loss | 238.13 | 178.57 | 235.33 | 168.96 | 118.39 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 10.46 | 9.51 | 9.51 | 9.51 | 9.51 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 40.24 | 38.33 | 53.07 | 39.83 | 41.39 |
| GPM (%) | 42.10 | 39.55 | 54.03 | 43.17 | 43.50 |
| NPM (%) | 26.80 | 24.25 | 37.32 | 31.08 | 26.11 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis